|
Characterization of patient-derived organoids cultured on a gas-rich, liquid-liquid interface. Shoemaker JT, Richardson KR, Arnst J, Marcus AI and Vukasinovic J. American Association for Cancer Research 2019. Proceedings: Abstracts 1-2748
|
| ||
|
Xiong Y, He L, Shay C, Lang L, Loveless J, Yu J, Chemmalakuzhy R, Jiang H, Liu M, Teng Y. Nck-associated Protein 1 Associates with HSP90 to Drive Metastasis in Human Non-Small-Cell Lung Cancer. J Exp Clin Cancer Res. 2019, 38(1):122. DOI: 10.1186/s13046-019-1124-0
https://jeccr.biomedcentral.com/articles/10.1186/s13046-019-1124-0 |
| ||
|
Neuroimmune activation and off-target toxicity testing of cell therapies using a novel brain-on-a-chip system. J.T. Shoemaker, J. Vukasinovic, C. Xu, Z. Wen, and M.C. LaPlaca. Society for Neuroscience 2018.
|
| ||
|
A perfused three-dimensional culture model of human cortical tissue.
J. Vukasinovic, J.T. Shoemaker, and M.C. LaPlaca. Society for Neuroscience 2018. |
| ||
|
Progress towards the development of a fully humanised 3D cell culture model of HER2+ breast cancer. Sophie Roberts, Danah Al’Qallaf, Sally A. Peyman, Darren Tomlinson, J.T. Shoemaker, Jelena Vukasinovic and Valerie Speirs. Breast Cancer Res Treat (2018) 167: 309. DOI: 10.1007/s10549-017-4585-x
https://link.springer.com/article/10.1007%2Fs10549-017-4585-x |
|
Cytochrome P450 enzyme activity is enhanced in hepatocytes grown using a perfused 3D cell culture drug screening system. Shoemaker J.T. and Vukasinovic J. American Association for Cancer Research 2017. Volume 77, Issue 13 Supplement, pp. 4080. DOI: 10.1158/1538-7445.AM2017-4080
http://cancerres.aacrjournals.org/content/77/13_Supplement/4080 |
| ||
|
A perfused 3D cell culture platform for preclinical drug screening.
Shoemaker J.T. and Vukasinovic J. New Frontiers in 3D Cell Culture-based Screening Technologies. October 13, 2016. Baltimore, MD, USA |
| ||